Diabetes Nutrition Market Size to Exceed USD 10,080.2 Mn by 2032

The Diabetes Nutrition Market, estimated at USD 6,486.7 Mn in 2025, is expected to exhibit a CAGR of 6.5% and reach USD 10,080.2 Mn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

Increasing number of funding by various authorities in order to increase the advancement of diabetes nutrition is expected to drive the global diabetes nutrition market growth over the forecast period. For instance, in August 2025, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) anoounced that they had awarded US$ 4 million to support a collaboration betweeen the Nutrition Obesity Research Center (NORC) at the UNC Gillings School of Global Public Health and the North Carolina Diabetes Research Center that will provide career advancement for nutrition, obesity and diabetes researchers from underrepresented groups.

Global Diabetes Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

The COVID-19 pandemic also had a positive impact on the global diabetes nutrition market. For instance, in September 2025, according to the data published in National Center for Biotechnology Information,  a survey was conducted in Poland in 124 individulas having type 1 diabetes to assess the nutrition and health behavior among them. It was estimated that over 60% of all participants declared that they had started eating more nutritious and regular meals during the COVID-19 pandemic and their disease self-management had significantly improved.

Global Diabetes Nutrition Market: Key Developments

Ongoing research and development by key market players is expected to drive the global diabetes nutrition market over the forecast period. For instance, in February 2025, Oramed, a pharmaceutical company, started a clinical trial to evaluate the safety and efficacy of ORMD-0801, oral insulin in subjects with type 2 diabetes mellitus. The trial is expected to complete in October 2025.

Browse 53 Market Data Tables and 50 Figures spread through 170 Pages and in-depth TOC on “Global Diabetes Nutrition Market”- Forecast to 2032, Global Diabetes Nutrition Market, by Form (Fixed Dental Prosthetic (Tablets, Capsules, Powders, Soft Gels, Liquids), by Product Type (Proteins & Amino Acids, Omega-3 Fatty Acids, Alpha-Lipoic Acid (ALA), Herbal Supplements, Soluble Fiber, Probiotics, Carbohydrates, Others (Antioxidants, etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/diabetes-nutrition-market-2890

Moreover, increasing adoption of inorganic strategies such as product launches by key market players is expected to drive the global diabetes nutrition market growth over the forecast period. For instance, in November 2025, Dr. Reddy’s Laboratories Ltd., a pharmaceutical company, announced that they had launched Celevida, a diabetic friendly drink which is used to manage blood glucose level among the diabetic patient.

Key Takeaways of the Global Diabetes Nutrition Market:

• The global diabetes nutrition market is expected to exhibit a CAGR of 6.5% during the forecast period due to the increasing adoption of growth strategies such as product launches by the key market players. For instance, in October 2025, Glenmark Pharmaceuticals Limited, a pharmaceutical company announced that they had launched Zita D tablets for the treatment of type 2 diabetes. It is used to improve glycemic control & prevent complications in adult patients with type 2 diabetes.
• Among indication, type 2 diabetes segment is estimated to hold a dominant position in the global diabetes nutrition market over the forecast period due to the adoption of inorganic strategies such as product launches by key market players. For instance, in October 2025, Glenmark Pharmaceuticals Limited, a pharmaceutical company announced that they had launched a fixed dose combination (FDC) of Remogliflozin, Vildagliptin and Metformin in India, which is indicated for the treatment of type 2 diabetes.
• Among regions, North America is estimated to account for the largest market share in the global diabetes nutrition market, owing to the increasing adoption of inorganoic strategies such as product approval by key market players over the forecast period. For instance, in September 2025, Novo Nordisk A/S, a pharmaceutical company announced that they had received an approval from U.S. Food and Drug Administration for Rybelsus (semaglutide), oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, Rybelsus is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the U.S.
• Major players operating in the global diabetes nutrition market include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical  Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players.